相关实验视频

Updated: Jun 18, 2025

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

血液学特征和替代诊断在严重病情的血栓性抗脂综合征患者

Levi-Dan Azoulay¹, Thomas Frapard¹, Romaric Larcher²

¹Syndrome Des Anticorps Anti-Phospholipides Et Autres Maladies Auto-Immunes Systémiques Rares, Sorbonne Université, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital La Pitié-Salpêtrière, Institut E3M, Service de Médecine Interne 2, Centre de Référence National Lupus Systémique, Paris, France.

Clinical rheumatology

|July 29, 2024

概括

在ICU中的严重抗脂综合征 (APS) 通常会导致贫血和血小板狭窄. 血小板缺血,尤其是低于20G/L的血小板缺血,在重症APS患者中显著增加死亡风险.

科学领域:

血液学血液学血液学
临界护理医学临界护理医学
免疫学免疫学免疫学

背景情况:

严重的血栓性抗脂综合征 (APS) 可以影响重要器官,但其在危急病患者的血液学表现,特别是那些在ICU,并没有很好地定义.
了解这些血液学问题对于管理灾难性抗脂综合征 (CAPS) 至关重要.

研究的目的:

描述患有血栓性APS和CAPS的重症患者的血液学表现.
研究这些血液学问题的频率,临床表现和结果.

主要方法:

从2000年到2018年,法国进行了一项回顾性,全国性的多中心研究.
包括在内的是被录入24个重症监护室的APS患者,他们出现了新的血栓事件.
分析了血液学表现的患病率和相关结果.

主要成果:

在134名APS患者中,贫血 (95%) 和血小板缩 (93%) 非常普遍.
血小板计数低于20G/L与显著更高的ICU死亡率 (50%) 有关.
血栓性微血管病综合征 (TMA) 发生在12%的患者中,传播性血管内凝血 (DIC) 发生在51%的患者中.

结论:

血栓缩是严重APS和CAPS的关键血液学发现.
血小板缺血的机制,包括TMA,肝素诱导的血小板缺血 (HIT) 和DIC,需要仔细研究以获得最佳的患者管理.
在CAPS患者中,研究HIT等替代诊断是必不可少的.

关键词:

亚当斯13 亚当斯13 抗脂综合征是一种抗脂综合征.灾难性的抗脂蛋白综合征肝素诱导的血小板缺血.在重症监护病房的重症监护病房.

更多相关视频

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

Microfluidics in Assessing Platelet Function

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

相关概念视频

Disorders of Hemostasis

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Structure and Function of Platelets

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...